Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy

Cytokine

Volumn 49, Issue 3, 2010, Pages 325-330

  Del Ry, Silvia ^a   Giannessi, Daniela ^a   Maltinti, Maristella ^a   Cabiati, Manuela ^b   Prontera, Concetta ^a   Iervasi, Annalisa ^a   Caselli, Chiara ^a   Mazzone, Anna Maria ^a   Neglia, Danilo ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Dilated cardiomyopathy (DCM); Idiopathic left ventricular dysfunction (ILVDys); Myocardial blood flow (MBF); Osteopontin (OPN)

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; OSTEOPONTIN; RENIN;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ALDOSTERONE; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; FEMALE; HUMANS; INFLAMMATION; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIUM; OSTEOPONTIN; REGIONAL BLOOD FLOW; RENIN; VENTRICULAR DYSFUNCTION, LEFT;

EID: 75449085881     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.11.018     Document Type: Article

References (27)

1. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
2. Terasaki F., Okamoto H., Onishi K., Sato A., Shimomura H., Tsukada B., et al. Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodelling in patients with dilated cardiomyopathy. Circ J (2007) 327-330
3. Treasure C.B., Vita J.A., Cox D.A., Fish R.D., Gordon J.B., Mudge G.H., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81 (1990) 772-779
4. Drexler H., Hayoz D., Munzel T., Horning B., Just H., Brunner H.R., et al. Endothelial function in chronic heart failure. Am J Cardiol 69 (1992) 1596-1601
5. Neglia D., Parodi O., Gallopin M., Sambuceti G., Giorgetti A., Pratali L., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. Circulation 92 (1995) 796-804
6. Neglia D., De Caterina A., Maraccini P., Natali A., Ciardetti M., Vecoli C., et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 293 (2007) H3270-H3278
7. Neglia D., Michelassi C., Trivieri M.G., Sambuceti G., Giorgetti A., Pratali L., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 105 (2002) 186-193
8. Gravallese E.M. Osteopontin: a bridge between bone and the immune system. J Clin Invest 112 (2003) 147-149
9. Butler W.T. The nature and significance of osteopontin. Connect Tissue Res 23 (1989) 123-136
10. Giachelli C.M., Schwartz S.M., and Liaw L. Molecular and cellular biology of osteopontin. Potential role in cardiovascular disease. Trends Cardiovasc Med 5 (1995) 88-95
11. Riedl M., Vila G., Maier C., Handisurya A., Shakeri-Manesch S., Prager G., et al. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab 93 6 (2008) 2307-2312 [Epub 2008 Mar 11]
12. Marchesi C., Paradis P., and Schiffrin E.L. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci (2008) 367-374
13. Stawowy P., Blaschke F., Pfautsch P., Goetze S., Lippek F., Wollert-Wulf B., et al. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail (2002) 139-146
14. Singh K., Sirokman G., Communal C., Conrad C.H., Brooks W.W., Bing O.H., et al. Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 33 (1999) 663-670
15. Williams E.B., Halpert L., Wickline S., Davison G., Parks W., and Rottman J. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation 92 (1995) 705-709
16. Ashizawa N., Graf K., Do Y.S., Nunohiro T., Giachelli C.M., Meehan W.P., et al. Osteopontin is produced by rat cardiac fibroblast and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest 98 (1996) 2218-2227
17. Murry C., Giachelli C.M., Schwartz S., and Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145 (1994) 1450-1462
18. Heling A., Zimmermann R., Kostin S., Maeno Y., Hein S., Devaux B., et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. Circ Res 86 (2000) 846-853
19. Xie Z., Singh M., and Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44 6 (2004) 826-831
20. Bielecka-Dabrrowa A., Wierzbicka M., Dabrowa M., and Goch A. New methods in laboratory diagnostics of dilated cardiomyopathy. Cardiol J 15 (2008) 388-395
21. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
22. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., and Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med 40 4 (2002) 371-377
23. Pilo A., Zucchelli G.C., Malvano R., and Masini S. Main features of computer algorithms for RIA data reduction. Comparison of same different approaches for the interpolation of dose-response curve. J Nucl Med Allied Sci 26 (1982) 235-248
24. Brown N.J. Aldosterone and vascular inflammation. Hypertension 51 (2008) 161-167
25. Murry C.E., Giachelli C.M., and Schwaetz S.M. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145 (1994) 1450-1462
26. Collins A.R., Schnee J., Wang W., Kim S., Fishbein M.C., Bruemmer D., et al. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart. J Am Coll Cardiol 43 (2004) 1698-1705
27. Parodi O., De Maria R., Oltrona L., Testa R., Sambuceti G., Roghi A., et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 88 2 (1993) 509-522